glp-1 for diabetes type 2 Receptor Agonists | Incretin Therapies GLP-1 RA, GIP/GLP-1 RA and

[2] [3] Understanding the full safety profile of GLP-1 medications, including potential effects on vision, remains essential for both prescribers and patients as use of these agents continues to expand rapidly across diverse patient populations

Key gaps include safety in people with SIBO, autoimmune conditions, advanced liver disease, and other complex chronic illnesses - groups that were underrepresented in studies

The market is expanding at a CAGR of 5.28% between 2025 and 2034

Clinical Update 5/28/2026 Collagen for "Ozempic Face?" Does taking collagen prevent or reduce sagging skin due to rapid loss of weight with GLP-1 receptor agonists (i.e., "Ozempic face")

Stay Physically Active Exercise is your ally in weight maintenance

Some providers say wait two weeks